Réponse selon RECIST 1.0 / RECIST 1, p.40 ,
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease, Annals of Oncology, vol.16, issue.suppl_1, pp.53-57, 2007. ,
DOI : 10.1093/annonc/mdi814
The 2008 WHO lymphoma classification, Ann Pathol, vol.28, issue.1, 2008. ,
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma, Annals of Oncology, vol.16, issue.suppl_1, pp.55-61, 2007. ,
DOI : 10.1093/annonc/mdi820
Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.328, issue.14, pp.1002-1008, 1993. ,
DOI : 10.1056/NEJM199304083281404
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study, J Clin Oncol, vol.18, issue.16, pp.3025-3055, 2000. ,
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma ,
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte, J ,
Principles of clinical trials, Textbook of Medical Oncology, 2000. ,
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, issue.2, pp.228-275, 2009. ,
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol, vol.17, issue.4, pp.1244-53, 1999. ,
International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma, J Clin Oncol, vol.25, issue.5, pp.579-86, 2007. ,
Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria, Leukemia & Lymphoma, vol.115, issue.3, pp.513-533, 2007. ,
DOI : 10.1200/JCO.2005.08.955
Imaging of Abdominal and Pelvic Lymph Nodes Lymphography or Computed Tomography?, Investigative Radiology, vol.17, issue.5, pp.433-476, 1982. ,
DOI : 10.1097/00004424-198209000-00001
Abdominal lymphadenopathy: spectrum of CT findings., RadioGraphics, vol.11, issue.3, pp.457-72, 1991. ,
DOI : 10.1148/radiographics.11.3.1852937
Post-Therapy CT-Detected Mass in Lymphoma Patients, Journal of Computer Assisted Tomography, vol.6, issue.4, pp.792-797, 1982. ,
DOI : 10.1097/00004728-198208000-00025
Upper abdominal lymph nodes: criteria for normal size determined with CT., Radiology, vol.180, issue.2, pp.319-341, 1991. ,
DOI : 10.1148/radiology.180.2.2068292
Normal mediastinal lymph nodes: number and size according to ,
DOI : 10.2214/ajr.144.2.261
URL : http://www.ajronline.org/doi/pdf/10.2214/ajr.144.2.261
The number and size of normal mediastinal lymph nodes: a postmortem study, American Journal of Roentgenology, vol.150, issue.4, pp.771-777, 1988. ,
DOI : 10.2214/ajr.150.4.771
Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy, The British Journal of Radiology, vol.54, issue.807 ,
DOI : 10.1148/radiology.183.1.1549675
Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma, Langenbeck's Archives of Surgery, vol.13, issue.5, pp.543-550, 2007. ,
DOI : 10.2214/ajr.150.4.771
Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings, Respiration, vol.70, issue.5 ,
DOI : 10.1159/000074207
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm, Ann Oncol, vol.17, issue.6, pp.1018-1041, 2006. ,
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting., Journal of Clinical Oncology, vol.7, issue.11, pp.1630-1636, 1989. ,
DOI : 10.1200/JCO.1989.7.11.1630
Response criteria for NHL: Importance of ???normal??? lymph node size and correlations with response rates, Annals of Oncology, vol.11, issue.4, pp.399-408, 2000. ,
DOI : 10.1023/A:1008332713631
Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and thio phosphoamide, J Chronic Dis, vol.11, issue.1, pp.7-33, 1960. ,
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for post treatment evaluation in ,
18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma, Annals of Oncology, vol.12, issue.1 ,
DOI : 10.1023/A:1008357126404
Positron-Emission Tomography and Assessment of Cancer Therapy, New England Journal of Medicine, vol.354, issue.5, pp.496-507, 2006. ,
DOI : 10.1056/NEJMra050276
Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease, J Clin Oncol, vol.8, issue.9, p.1598, 1990. ,
Measurement of tumour response to cancer treatment: morphologic imaging role, Bull Cancer, vol.94, issue.2, pp.171-178, 2007. ,
Re: Measure Once or Twice Does It Really Matter?, JNCI Journal of the National Cancer Institute, vol.91, issue.6, pp.1780-1781, 1999. ,
DOI : 10.1093/jnci/91.6.523
URL : https://academic.oup.com/jnci/article-pdf/91/20/1780/7795691/1780.pdf
Evaluation of tumour response to treatment with targeted therapies: standard or targeted criteria? Bull Cancer, pp.231-240, 2007. ,
A statistical simulation study finds discordance between WHO criteria and RECIST guideline, Journal of Clinical Epidemiology, vol.57, issue.4, pp.358-65, 2004. ,
DOI : 10.1016/j.jclinepi.2003.07.015
Restaging laparotomy in the management of the ,
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management, J Clin Oncol, vol.6, issue.12, pp.1832-1869, 1988. ,
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma., Journal of Clinical Oncology, vol.7, issue.8, pp.1018-1044, 1989. ,
DOI : 10.1200/JCO.1989.7.8.1018
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma, J Clin Oncol, vol.11, issue.11, pp.2273-2281, 1993. ,
Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake, J Clin Oncol, vol.13, issue.4, pp.942-948, 1995. ,
Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma, J Clin Oncol, vol.14, issue.9, pp.2473-2482, 1996. ,
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma, British Journal of Haematology, vol.238, issue.3, pp.293-302, 2006. ,
DOI : 10.1007/s00277-001-0390-y
18F- fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: A systematic review, Haematologica, vol.91, issue.4, pp.522-531, 2006. ,
FDG PET monitoring of tumour response to chemotherapy: does (18)FDG uptake correlate with the viable tumour cell fraction? ,
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome, Blood, vol.106, issue.4, pp.1376-81, 2005. ,